IMRN
Immuron Ltd ADR
NASDAQ: IMRN · HEALTHCARE · BIOTECHNOLOGY
$0.82
+1.86% today
Updated 2026-04-30
Market cap
$7.11M
P/E ratio
—
P/S ratio
0.95x
EPS (TTM)
$-0.53
Dividend yield
—
52W range
$1 – $2
Volume
0.0M
Immuron Ltd ADR (IMRN) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-62.10%
Operating margin
-47.20%
ROE
-39.70%
ROA
-21.90%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $4.00M | $-3.56M | 35.61% | -109.21% | -88.95% |
| 2007 | $4.25M | $-3.28M | 9.86% | -108.28% | -77.22% |
| 2008 | $292904.00 | $-2.86M | 7.47% | -1,362.97% | -975.86% |
| 2009 | $524102.00 | $-2.32M | 67.00% | -566.78% | -442.24% |
| 2010 | $461890.00 | $-1.91M | 40.37% | -490.26% | -412.61% |
| 2011 | $213951.00 | $-2.60M | -1.26% | -1,350.44% | -1,212.98% |
| 2012 | $449012.00 | $-2.30M | 19.00% | -735.61% | -511.68% |
| 2013 | $149755.00 | $-3.54M | 22.79% | -2,164.35% | -2,363.27% |
| 2014 | $1.00M | $-2.69M | 64.94% | -426.90% | -268.54% |
| 2015 | $1.00M | $-2.69M | 64.94% | -426.90% | -268.54% |
| 2016 | $1.00M | $-7.07M | 69.47% | -825.34% | -706.12% |
| 2017 | $1.40M | $-6.80M | 66.05% | -600.86% | -487.33% |
| 2018 | $1.84M | $-3.01M | 68.40% | -162.13% | -163.38% |
| 2019 | $2.39M | $-4.66M | 71.49% | -195.04% | -195.04% |
| 2020 | $2.52M | $-2.90M | 72.65% | -115.82% | -115.33% |
| 2021 | $145776.00 | $-8.38M | -456.22% | -5,748.48% | -5,751.61% |
| 2022 | $765193.00 | $-2.85M | 68.41% | -375.05% | -373.01% |
| 2023 | $1.80M | $-3.79M | 96.42% | -197.75% | -209.81% |
| 2024 | $4.90M | $-6.94M | 68.06% | -118.32% | -141.49% |
| 2025 | $7.29M | $-5.22M | 65.39% | -73.34% | -71.58% |